MedPath

To determine the role of catheter based VT ablation in the prevention of recurrent VT in post-MI patients who survive a life-threatening VT/VF event but cannot afford an implantable defibrillator. Patients will be randomized to either Amiodarone or Amiodarone plus catheter ablation.

Phase 3
Conditions
Health Condition 1: null- Ventricular Tachycardia
Registration Number
CTRI/2012/07/002827
Lead Sponsor
CARE Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
132
Inclusion Criteria

more than 18 and less than 85 years of age

History of a remote MI of more than 1 month

Survival of a ventricular arrhythmic event VT or VF that would mandate placement of an implantable cardioverter-defibrillator

Patient cannot afford an ICD and thus has been planned for treatment with Amiodarone

Ability to understand the requirements of the study

Willingness to adhere to study restrictions and comply with all postprocedural follow-up requirements

Exclusion Criteria

Patients with NYHA class IV congestive heart failure

Prior ablation for a ventricular arrhythmia

Presence of an LV thrombus

Contraindication to anticoagulation

Inability to access the endocardium because of mechanical mitral and aortic valve

Life expectancy of less than 1 year for any medical condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause mortality and Cardiac Arrest and Sustained VTTimepoint: 24 months
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects that die within 30 days or by the end of the study <br/ ><br>Total number of ventricular arrhythmic events, compared between the 2 treatment arms. <br/ ><br>Differences in LV ejection fraction between paired measurements recorded at baseline and 3 months for each patient will be used to test for significant differences between the two treatment arms. <br/ ><br>Quality of life. <br/ ><br>Timepoint: 30days <br/ ><br>24months <br/ ><br>3 months
© Copyright 2025. All Rights Reserved by MedPath